Vita Nova Insights
Formed in 2024 Vita Nova InsightsSM offers unique and truly differentiated precision oncology insights and real-world evidence solutions. From preliminary consultation, through study design, clinical end-point review, delivery of rich clinical data set, and comprehensive clinical insights, our Vita Nova Insights team uses a thorough, multifaceted, collaborative approach for all study types.
Real-World Evidence Study Types
- Real-World Evidence: Retrospective & prospective data, analysis, and “evergreen” datasets (subscriptions)
- Prospective Studies: ‘Non-interventional’ Patient Reported Outcomes (PROs)
- Quality Improvement: Studies that focus on understanding diagnostic testing patterns, how pharmaceutical products perform in the real-world, identification of improvement opportunities, physician surveys, and development of comprehensive educational and alerting programs to close gaps.
- Health Equity: Health disparities across socio-demographic groups have become critical in ensuring there is access to appropriate care, new therapies, and trials, optimized to socio-demographic classes and/or geographic regions.
- Clinical Research: Identification of patients eligible for research studies; trial/site feasibility assessment, preliminary matching of patients to trials.
- New Product Launch: Identification, notification and monitoring of patients potentially eligible for a new product or existing product approved for a new indication.
- Market Access: Market analysis to understand penetration of the FCS market, and inisights to contributing factors, such as physician, patient or payer preferences; presented through dynamic dashboards.
Our Data
Vita Nova Insights utilizes industry-leading data science, artificial intelligence, its deep clinical oncology expertise, and physician engagement strategies to generate insights that help optimize patient care, enable clinical research, and convert FCS’ real-world data into the real-world evidence needed for the discovery and development of new therapies.
Vita Nova Insights works in partnership and collaboration with, Florida Cancer Specialists & Research Institute (FCS), one of the country’s largest community oncology practices that conducts over 3 million patient visits annually in nearly 100 locations and treats a wide variety of cancer-related conditions ranging from extremely rare diagnoses to the more commonly occurring disorders.
Vita Nova Insights supports physicians’ and clinical researchers’ access to diversified data assets collected from EMR, practice management, genomics, oral oncolytic pharmacy, laboratory, radiology, and radiation oncology systems. Information gleaned from our experience caring for over one million patients annually is standardized against industry reference data and further enriched using external data sources to create a more comprehensive picture of the health of every patient.
Data Curation
Our data curation team consists of highly trained oncology nurse data curators who have experience in FCS clinics to produce high-quality data sets, including data enrichment and comprehensive analysis services. By having direct access to the data and our FCS physicians, our data curation team interrogates the data at the source to provide insights and drives quality improvement activities to address gaps in care or knowledge to improve clinical outcomes and patient experience.
Leadership Team
Trevor Heritage
Senior Vice President & Data Officer
Amy Ming
Senior Director of Informatics
To learn more, or to have a Vita Nova Insights consultant reach out to you, please email: Insights@VitaNovaInsights.com.
Data Stewardship
Our process of obtaining, cleaning, justifying, and converting FCS’ real-world data into meaningful real-world evidence involves a series of steps to ensure accuracy, completeness, quality, and relevance, including:
Data Curation
Data Standardization and Normalization
AI & NLP Processing
De-Identification
Data Enrichment
Data Governance
Vita Nova Insights, LLC d/b/a Vita Nova InsightsSM is wholly owned by Community Oncology Revitalization Enterprise, LLC (Core Ventures), FCS’ management services organization.
